GlassScriptPhysician profile
Eric Sean Lee
NPI 1356329981
$2,326.76
in general payments reported to CMS, 2019-2025
15 companies · $1,085 in 2025
The $1,085 reported for 2025 was more than what 75% of Retina Specialist providers received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $52.68 · 2021: $40.38 · 2022: $313 · 2023: $321 · 2024: $312 · 2025: $1,085.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,718.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Apellis Pharmaceuticals, INC. | $495.76 | 2023-2025 | Syfovre |
| Astellas Pharma US INC | $319.16 | 2023-2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $294.65 | 2022-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $271.81 | 2021-2025 | |
| Genentech USA, INC. | $239.99 | 2019-2025 | Vabysmo |
| Genentech, INC. | $150.31 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $135.57 | 2025 | Xdemvy |
| Pfizer INC. | $92.70 | 2019-2025 | |
| Dutch Ophthalmic, USA | $87.91 | 2023 | Eva, Combined Machine, Tissueblue |
| Novartis Pharmaceuticals Corporation | $87.34 | 2019-2020 | |
| Alimera Sciences, INC. | $56.10 | 2019-2022 | |
| Allergan, INC. | $36.33 | 2019-2020 | |
| Ani Pharmaceuticals, INC. | $24.65 | 2025 | Iluvien |
| Coherus Oncology, INC. | $18.24 | 2023 | |
| Akorn, INC. | $16.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.